Search

Search Results

• CO097 | IMPACT OF THE 2023 ACR/EULAR ANTIPHOSPHOLIPID SYNDROME CRITERIA IN 1200 WOMEN WITH PRIOR OBSTETRIC ANTIPHOSPHOLIPID SYNDROME J. Alijotas-Reig^1|2|3, E. Esteve-Valverde⁴, L. Saez-Comet⁵, A. Anunciacion-Llunell³, R. Ferrer-Oliveras⁶, E. Lefkou⁷, A. Mekinian⁸, C. Belizna⁹, A. Hoxha¹⁰, A. Tincani¹¹, L. Marozio¹², G. Espinosa¹³, S. de Carolis¹⁴, S. Udry¹⁵, J.O. Latino¹⁵, E. Llurba¹⁶, C.B. Chighizola^17|18, M. Gerosa¹⁹, V. Pengo²⁰, K. Lundelin²¹, P. Rovere-Querini²², V. Canti²², K. Mayer-Pickel²³, T. Reshetnyak²⁴, S. Tabacco²⁵, L. Stojanovich²⁶, B.A. Gonçalves²⁷, S. Morales-Perez¹, F. Miro-Mur³ | ¹Department of Medicine, Universitat Autonoma de Barcelona, Spain; ²Systemic Autoimmune Disease Unit, Department of Internal Medicine, Vall d’Hebron University Hospital, Spain; ³Systemic Autoimmune Diseases Research Unit, Vall d’Hebron Institut de Recerca, Barcelona, Spain; ⁴Systemic Autoimmune Diseases Unit, Department of Internal Medicine, Hospital Sant Camil, Consorci Sanitari del Garraf, Barcelona, Spain; ⁵Department of Internal Medicine, Hospital Universitario Miguel Servet, Zaragoza, Spain; ⁶Obstetrics Department, High-Risk Unit, Hospital Universitario Quironsalud, Barcelona, Spain; ⁷Haematology Unit, Hippokration Hospital of Thessaloniki, Greece; ⁸AP-HP, Hopital Saint-Antoine, Service de Medecine Interne and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Sorbonne Universites, Paris, France; ⁹Vascular and Coagulation Department, University Hospital Angers, Angers, France; ¹⁰Internal Medicine Unit, Thrombotic and Bleeding Disorder Center, University of Padua, Padova, Italy; ¹¹Department of Clinical and Experimental Sciences, University of Brescia, Spedali Civili, Brescia, Italy; ¹²Department of Obstetrics and Gynaecology, Universita di Torino, Torino, Italy; ¹³Systemic Autoimmune Diseases Service, Hospital Clínic, Universitat de Barcelona, Barcelona, Spain; ¹⁴Department of Gynaecology, Gemelli Hospital, Catholic University, Roma, Italy; ¹⁵Autoimmune, Thrombophilic Diseases and Pregnancy Division, Dr. Carlos G. Durand Hospital, Buenos Aires, Argentina; ¹⁶Obstetrics and Gynaecology Department, High-Risk Unit, University Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; ¹⁷Department of Clinical Science and Community Health, University of Milano, Milano, Italy; ¹⁸Unit of Pediatric Rheumatology, ASST G. Pini-CTO, Milano, Italy; ¹⁹Division of Rheumatology, Department of Clinical Sciences and Community Health, University of Milano, Milano, Italy; ²⁰Cardiology Unit, Department of Cardiac, Thoracic and Vascular Sciences, University of Padua, Padova, Italy; ²¹Department of Pediatrics, Faculty of Medicine, University of Turku, Turku, Finland; ²²Internal Medicine and Division of Immunology, Transplantation and Infectious Diseases, IRCCS Ospedale San Raffaele, Milano, Italy; ²³Department of Obstetrics, Medical University of Graz, Graz, Austria; ²⁴Department of Systemic Rheumatic Disease, V. A. Nasonova Research Institute of Rheumatology, Moscow, Russia; ²⁵Department of Gynecology, Obstetrics and Urology, Sapienza University of Roma, Roma, Italy; ²⁶University Medical Center, University of Belgrade, Belgrade, Serbia; ²⁷Department of Internal Medicine, Hospital Sant Joan Despí Moises-Broggi, Barcelona, Spain

  Ariela Hoxha

  26-10-2026

  https://doi.org/10.4081/btvb.2026.799

  0

  PDF: 0

• CO102 | VARIABILITY IN ANTIPHOSPHOLIPID ANTIBODY TESTING AND TREATMENT STRATEGIES IN OBSTETRIC ANTIPHOSPHOLIPID SYNDROME: RESULTS FROM THE OAPS-CARE SURVEY, ON BEHALF OF THE EUROPEAN FORUM ON ANTIPHOSPHOLIPID ANTIBODIES A. Hoxha^1|2, E. Esteve-Valverde^3|4, G. Gobbo^1|2, F. Miró-Mur⁴, M. Radin⁵, S. De Carolis⁶, C. Trilla^7|8|9|10, A. Tincani^11|12, R. Cervera^13|14, J. Alijotas-Reig^3|15|16 | ¹Department of Medicine - DIMED, University of Padua, Padova, Italy; ²Internal Medicine Unit, Thrombosis and Bleeding Disorder, University Hospital of Padua, Padova, Italy; ³Systemic Autoimmune Diseases Unit. Department of Internal Medicine, Hospital Sant Camil, Consorci Sanitari Alt-Penedes-Garraf, Sant Pere de Ribas, Barcelona, Spain; ⁴Systemic Autoimmune Disease Research Unit. Vall d'Hebron Institut de Recerca (VHIR), Barcelona, Spain; ⁵Center of Research of Immunopathology and Rare Diseases - Coordinating Center of Piemonte and Valle d'Aosta Network for Rare Diseases, SCDU Nephrology and Dialysis, School of Specialization of Clinical Pathology, Department of Clinical and Biological Sciences, S. Giovanni Bosco Hospital, University of Turin, Torino, Italy; ⁶Fondazione Policlinico Universitario A. Gemelli IRCCS, Dipartimento di Scienze per la salute della Donna e del Bambino e di Sanità Pubblica, Roma, Italy; ⁷Hospital de la Santa Creu i Sant Pau, Barcelona, Spain; ⁸Universitat Autònoma de Barcelona, Barcelona, Spain; ⁹Spanish Network in Maternal, Neonatal, Child and Developmental Health Research (RICORS-SAMID, RD24/0013/0001), Instituto de Salud Carlos III, 28040 Madrid, Spain; ¹⁰Women and Perinatal Health Research Group, Institut de Recerca (IR SANT PAU), Sant Quintí 77-79, 08041 Barcelona, Spain; ¹¹Rheumatology and Clinical Immunology Unit - ERN ReCONNET, ASST Spedali Civili, Brescia, Italy; ¹²Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy; ¹³Department of Autoimmune Diseases, Hospital Clínic, University of Barcelona, Barcelona, Catalonia, Spain; ¹⁴August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Catalonia, Spain; ¹⁵Department of Medicine. Universitat Autonoma de Barcelona, Barcelona, Spain; ¹⁶Systemic Autoimmune Disease Unit, Department of Internal Medicine, Vall d’Hebron University Hospital, Barcelona, Spain

  Ariela Hoxha

  26-10-2026

  https://doi.org/10.4081/btvb.2026.804

  0

  PDF: 0